Edesa Biotech, Inc. (EDSA) › Operating IncomeEdesa Biotech, Inc. (EDSA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$5.72M2015: -$4.34M2016: -$4.91M2017: -$5.22M2018: -$1.62M2020: -$6.40M2021: -$23.68M2022: -$18.37M2023: -$9.22M2024: -$7.01M2025: -$7.91M-$7.91M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$7.91M-12.8%2024-$7.01M+23.9%2023-$9.22M+49.8%2022-$18.37M+22.4%2021-$23.68M-270.0%2020-$6.40M—2018-$1.62M+69.0%2017-$5.22M-6.4%2016-$4.91M-13.1%2015-$4.34M+24.1%2014-$5.72M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share